Core Viewpoint - A securities class action lawsuit has been filed against Centene Corporation for allegedly misleading investors about its revenue outlook and growth projections during the specified class period [1][2]. Group 1: Allegations and Company Performance - The lawsuit claims that Centene misrepresented its revenue outlook and growth potential, while promoting favorable enrollment rates and low morbidity, which did not align with actual performance [2]. - On July 1, 2025, Centene withdrew its 2025 guidance, revealing that its market growth across 22 states was lower than expected, leading to a revised guidance of approximately $1.8 billion and an adjusted diluted EPS of $2.75 [3]. - Following the announcement of the revised guidance, Centene's stock price plummeted by over 40% [3]. Group 2: Investor Actions - Investors who acquired Centene shares during the class period are encouraged to contact the law firm Gainey McKenna & Egleston before the lead plaintiff motion deadline on September 8, 2025 [4].
Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Centene Corporation (CNC)
